Task Force on Chronic Interstitial Lung Disease in Immunocompetent Children

Total Page:16

File Type:pdf, Size:1020Kb

Task Force on Chronic Interstitial Lung Disease in Immunocompetent Children Copyright #ERS Journals Ltd 2004 Eur Respir J 2004; 24: 686–697 European Respiratory Journal DOI: 10.1183/09031936.04.00089803 ISSN 0903-1936 Printed in UK – all rights reserved ERS TASK FORCE Task force on chronic interstitial lung disease in immunocompetent children A. Clement*, and committee members Committee members: J. Allen, B. Corrin, R. Dinwiddie, H. Ducou le Pointe, E. Eber, G. Laurent, R. Marshall, F. Midulla, A.G. Nicholson, P. Pohunek, F. Ratjen, M. Spiteri, J. de Blic. All members of the Task Force contributed equally to the work. Task force on chronic interstitial lung disease in immunocompetent children. Correspondence: A. Clement, Dept de Pneumo- A. Clement, and committee members. #ERS Journals Ltd 2004. logie Pediatrique - INSERM E213, Hopital ABSTRACT: Chronic interstitial lung diseases in children represent a heterogeneous d9enfants Armand Trousseau, 26 Ave du group of disorders of both known and unknown causes that share common histological Dr Arnold Netter, 75571 Paris cedex 12, France. features. Despite many efforts these diseases continue to present clinical management Fax: 33 144736718 dilemmas, principally because of their rare frequency that limits considerably the E-mail: [email protected] possibilities of collecting enough cases for clinical and research studies. Through a Task Force conducted by the European Respiratory Society, which Keywords: Children, infant, interstitial lung comprised respiratory physicians and basic scientists from across Europe, 185 cases of disease, lung fibrosis interstitial lung diseases in immunocompetent children were collected and reviewed. The present report provides important clinically-relevant information on the current Received: August 5 2003 approach to diagnosis and management of chronic interstitial lung diseases in children. Accepted after revision: June 7 2004 In addition, recommendations for the management of paediatric interstitial lung diseases, as well as new insights into interstitial lung diseases pathophysiology during childhood are discussed. Eur Respir J 2004; 24: 686–697. Chronic interstitial lung diseases (ILD) represent a hetero- various paediatric pulmonary departments in European genous group of disorders of both known and unknown countries, and to collect cases of chronic ILD through a causes that share common histological features. To date, these questionnaire established by the group. This cohort is, thus, disorders have been poorly investigated in children; indeed fairly representative of practice across Europe. Data were most of the strategies used by paediatricians for diagnosis and then pooled and discussed through a series of meetings. treatment are derived from information provided by studies in Chronic ILD in immunocompetent children was defined as adult patients [1, 2]. However, there is increasing evidence the presence of respiratory symptoms and/or diffuse infiltrates that expression and outcome of chronic ILD in children on chest radiographs, abnormal pulmonary function tests differs from adult ILD. The present study was conducted as with evidence of restrictive ventilatory defect and/or impaired part of a European Respiratory Society (ERS) Task Force on gas exchange, and persistence of any of these findings for chronic ILD in immunocompetent children. The objectives of w3 months [1–5]. The medical records of children actively the Task Force were: 1) to provide information on the current managed for chronic ILD in European paediatric centres approach to diagnosis and management of chronic ILD in from 1997–2002 were reviewed. The records of 185 patients children; 2) to provide recommendations to clinicians for the with a diagnosis of chronic ILD were identified based on the diagnosis and management of chronic ILD in children; 3) to criteria defined above, and analysed. The exclusion criteria provide an update on the current understanding of the were lung diseases associated with immunodeficiency and/or pathophysiology of the disease(s) and on ongoing research malignancy. All the information regarding patient back- directions; and 4) to develop clinical and scientific collabora- ground including familial history, patient presentation, tions across the paediatric discipline and also with adult diagnostic evaluation, final diagnosis, treatment and outcome researchers to enable progress in the identification of were recorded through the questionnaire. All the results mechanisms underlying disease initiation and progression in were then collected into a database. In order to provide infants and older children. information on chronic ILD in young children, a subgroup of 58 patients aged v2 yrs was individualised. Results are presented as descriptive data and as mean¡SD. Review of the current approach to diagnosis and management of chronic ILD in children Patient presentation and diagnostic evaluation Study population Paediatric ILD occurred more frequently in the younger The Task Force included clinical respiratory physicians patients (fig. 1). A summary of the patients is listed in table 1. involved in paediatric and adult ILD, as well as basic The prevalence for development of chronic ILD was higher in scientists with expertise in cellular and molecular biology, young males than in young females. This is in agreement with and in genetics. Each member was assigned to contact the other reports [2, 6]. Medical record review of the family members indicated that nearly 10% of case siblings were For editorial comments see page 521. affected by similar diseases. CHRONIC INTERSTITIAL LUNG DISEASE IN CHILDREN 687 25 Table 2. – Diagnostic evaluation of the patients with interstitial lung disease 20 All patients Patients aged v2 yrs Patients n 185 58 15 Chest imaging Infiltrates 128 36 Ground glass pattern 34 11 Cases n 10 Honeycomb pattern 4 1 Pulmonary function tests Sa,O2 122 5 Sa,O2 v95% 73 36 Pa,O2 112 Hypoxaemia 67 26 0 Lung volume 108 <0.5>0.51 2 3 4 5 6 7 8 9 1011121314151617 Restriction 78 ND Age yrs Dco 75 Reduction 43 ND Fig. 1. – Age distribution (in yrs) of the patients with interstitial lung BAL diseases included in the European Respiratory Society Task Force study. Cell population data 98 98 Macrophage % 53.8¡20.9 65.2¡17.1 Lymphocyte % 32.2¡22.6 13.8¡11.6 Table 1. – Clinical presentation of the patients with interstitial Neutrophil % 11.3¡16.5 19.8¡20.5 lung disease Eosinophil % 1.2¡1.6 1.3¡1.6 ¡ All patients Patients aged v2 yrs Data are presented as n or mean SD. Sa,O2: arterial oxygen saturation; Pa,O2: arterial oxygen tension; Dco: diffusion capacity for carbon n% n % monoxide; BAL: Bronchoalveolar lavage; ND: not determined. Patients n 185 58 and neutrophilia; however, in the younger aged children BAL Sex male/female 108/77 58/42 35/23 60/40 cell populations were predominantly neutrophils. Ethnic origin The main laboratory tests performed were microbiology Caucasian 162 87.6 52 89.7 tests, with data available in 111 cases. Positive results were Black 18 9.7 4 6.9 found in 10 samples, with the detection of adenovirus (one Other 5 2.7 2 3.4 case), Epstein Barr virus (EBV; four cases), Influenza virus Parental consanguinity 13 7 5 9 (one case), parvovirus (one case), cytomegalovirus (two cases) Affected siblings 18 10 8 7 and Mycoplasma pneumoniae (one case). The other laboratory Symptoms tests were performed according to the patient history and Cough 145 78 42 73 clinical presentation. Search for circulating auto-antibodies Tachypnoea/dyspnoea 140 76 49 84 was done in 99 samples with positive results in 12 cases. Failure to thrive 68 37 36 62 Elevated levels of angiotensin converting enzyme (ACE) were Fever 37 20 17 29 performed in 10 cases, and screening tests for hypersensitivity Physical findings pneumonitis were considered positive for 20 children. Cyanosis 51 28 31 54 Lung biopsy data were available in 107 cases. Analysis of Clubbing 24 13 5 9 Crackles 81 44 33 57 the diagnostic procedures performed indicated that open lung biopsies were predominantly performed (62%), followed by transbronchial biopsies (26%), video assisted thoracoscopy The majority of patients had symptoms for v1 yr at the biopsies (VATB) (7%), and transthoracic percutaneous time of initial evaluation. The mean duration of symptoms biopsies (5%). before diagnosis was 6.6¡0.5 months. Most children pre- sented with cough and tachypnoea (table 1). Failure to thrive was documented in almost two thirds of the patients Diagnosis diagnosed before aged 2 yrs. Chest radiographs were performed in all patients, but high- A diagnosis was made in 177 of 185 patients, and in 56 of resolution computed tomography (HRCT) scanning data 58 cases in the subgroup of children aged v2 yrs. The list is were available in only 131 of 185 cases (and in 37 of 58 given in table 3, including the number of lung biopsies patients aged v2 yrs). Abnormalities at the time of initial performed. Some can be considered as specific diagnoses, in evaluation were predominantly interstitial infiltrates (table 2). accordance with the standard classification of chronic ILD Analysis of the pulmonary function data showed large [6, 7]. They include pulmonary haemosiderosis, pulmonary variations in the methods used by the various paediatric alveolar proteinosis, hypersensitivity pneumonitis, Langerhans centres. The results summary of gas exchange analysis, lung cell histiocytosis, sarcoidosis, pulmonary lymphangioleiomyo- volumes, and diffusion capacity for carbon monoxide (Dco) matosis, lymphocyte infiltrative disorders, and auto-immune tests that could be included in the present review are related
Recommended publications
  • Lipoid Pneumonia
    PRACA ORYGINALNA Piotr Buda1, Anna Wieteska-Klimczak1, Anna Własienko1, Agnieszka Mazur2, Jerzy Ziołkowski2, Joanna Jaworska2, Andrzej Kościesza3, Dorota Dunin-Wąsowicz4, Janusz Książyk1 1Department of Pediatrics, The Children’s Memorial Health Institute, Warsaw, Poland Head: Prof. J. Książyk, MD, PhD 2Department of of Pediatric Pneumonology and Allergology, Medical University of Warsaw, Poland Head: M. Kulus, MD, PhD 3Department of Radiology, CT unit, The Children’s Memorial Health Institute, Warsaw, Poland Head: E. Jurkiewicz MD, PhD 4Department of Neurology and Epileptology, The Children’s Memorial Health Institute, Warsaw, Poland Head: S. Jóźwiak, MD, PhD Lipoid pneumonia — a case of refractory pneumonia in a child treated with ketogenic diet Tłuszczowe zapalenie płuc u dziecka leczonego dietą ketogenną — przypadek kliniczny The Authors declare no financial disclosure. Abstract Lipoid pneumonia (LP) is a chronic inflammation of the lung parenchyma with interstitial involvement due to the accu mulation of endoge- nous or exogenous lipids. Exogenous LP (ELP) is associated with the aspiration or inhalation of oil present in food, oil-based medications or radiographic contrast media. The clinical manifestations of LP range from asymptomatic cases to severe pulmonary involvement, with respiratory failure and death, according to the quantity and duration of the aspiration. The diagnosis of exogenous lipoid pneumonia is based on a history of exposure to oil and the presence of lipid-laden macrophages on sputum or bronchoalveolar lavage (BAL) analysis. High-resolution computed tomography (HRCT) is the imaging technique of choice for evaluation of patients with suspected LP. The best therapeutic strategy is to remove the oil as early as possible through bronchoscopy with multiple BALs and interruption in the use of mineral oil.
    [Show full text]
  • Practitioners' Section
    474 PRACTITIONERS’ SECTION LIPOID PNEUMONIA: AN UNCOMMON ENTITY G. C. KHILNANI, V. HADDA ABSTRACT Lipoid pneumonia is a rare form of pneumonia caused by inhalation or aspiration of fat-containing substances like petroleum jelly, mineral oils, certain laxatives, etc. It usually presents as an insidious onset, chronic respiratory illness simulating interstitial lung diseases. Rarely, it may present as an acute respiratory illness, especially when the exposure to fatty substance(s) is massive. Radiological findings are diverse and can mimic many other diseases including carcinoma, acute or chronic pneumonia, ARDS, or a localized granuloma. Pathologically it is a chronic foreign body reaction characterized by lipid-laden macrophages. Diagnosis of this disease is often missed as it is usually not considered in the differential diagnoses of community-acquired pneumonia; it requires a high degree of suspicion. In suspected cases, diagnosis may be confirmed by demonstrating the presence of lipid-laden macrophages in sputum, bronchoalveolar lavage fluid, or fine needle aspiration cytology/biopsy from the lung lesion. Treatment of this illness is poorly defined and constitutes supportive therapy, repeated bronchoalveolar lavage, and corticosteroids. Key words: Lipid-laden macrophages, lipoid pneumonia, mineral oil aspiration DOI: 10.4103/0019-5359.57639 PMID: 19901490 INTRODUCTION like parafÞ noma, cholesterol pneumonia, lipid granulomatosis, all denoting its association Lipoid pneumonia (LP) is a rare form of with the inhalation or ingestion of various pneumonia caused by inhalation or aspiration substances like petroleum jelly, mineral oils, of a fatty substance. It was Þ rst described in “nasal drops,” and even intravenous injection of 1925 by Laughlin and later by others in the olive oil.[5-13] Many of us are unfamiliar with this Þ rst half of the twentieth century.[1-4] Since then, condition, a fact that may be responsible for the there are many reports with different names underdiagnosis of LP.
    [Show full text]
  • Journal Pre-Proof
    Journal Pre-proof Presenting Clinico-radiologic Features, Causes, and Clinical Course of Exogenous Lipoid Pneumonia in Adults Bilal F. Samhouri, MD, Yasmeen K. Tandon, MD, Thomas E. Hartman, MD, Yohei Harada, MD, Hiroshi Sekiguchi, MD, Eunhee S. Yi, MD, Jay H. Ryu, MD PII: S0012-3692(21)00433-5 DOI: https://doi.org/10.1016/j.chest.2021.02.037 Reference: CHEST 4063 To appear in: CHEST Received Date: 20 December 2020 Revised Date: 14 February 2021 Accepted Date: 16 February 2021 Please cite this article as: Samhouri BF, Tandon YK, Hartman TE, Harada Y, Sekiguchi H, Yi ES, Ryu JH, Presenting Clinico-radiologic Features, Causes, and Clinical Course of Exogenous Lipoid Pneumonia in Adults, CHEST (2021), doi: https://doi.org/10.1016/j.chest.2021.02.037. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Copyright © 2021 Published by Elsevier Inc under license from the American College of Chest Physicians. 1 Word count: abstract –283, text – 3,108 2 Title: Presenting Clinico-radiologic Features, Causes, and Clinical Course of Exogenous Lipoid 3 Pneumonia in Adults 4 Short title: Exogenous Lipoid Pneumonia 5 Author list: 6 Bilal F.
    [Show full text]
  • Pathology of Allergic Bronchopulmonary Aspergillosis
    [Frontiers in Bioscience 8, e110-114, January 1, 2003] PATHOLOGY OF ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS Anne Chetty Department of Pediatrics, Floating Hospital for Children, New England Medical Center, Boston, MA TABLE OF CONTENTS 1. Abstract 2. Introduction 3. Immunopathogenesis 4. Pathologic Findings 4.1. Plastic bronchitis 4.2. Allergic fungal sinusitis 4.3. ABPA in cystic fibrosis 5. Acknowledgement 6. References 1. ABSTRACT Allergic bronchopulmonary aspergillosis (ABPA) individuals with episodic obstructive lung diseases such as occurs in patients with asthma and cystic fibrosis when asthma and cystic fibrosis that produce thick, tenacious Aspergillus fumigatus spores are inhaled and grow in sputum. bronchial mucus as hyphae. Chronic colonization of Aspergillus fumigatus and host’s genetically determined Decomposing organic matter serves as a substrate immunological response lead to ABPA. In most cases, for the growth of Aspergillus species. Because biologic lung biopsy is not necessary because the diagnosis is made heating produces temperatures as high as 65° to 70° C, on clinical, serologic, and roentgenographic findings. Some Aspergillus spores will not be recovered in the latter stages patients who have had lung biopsies or partial resections of composting. Aspergillus species have been recovered for atelectasis or infiltrates will have histologic diagnoses. from potting soil, mulches, decaying vegetation, and A number of different histologic diagnoses can be found sewage treatment facilities, as well as in outdoor air and even in the same patient. In the early stages the bronchial Aspergillus spores grow in excreta from birds (1) wall is infiltrated with mononuclear cells and eosinophils. Mucoid impaction and eosinophilic pneumonia are seen Allergic fungal pulmonary disease is manifested subsequently.
    [Show full text]
  • Exogenous Lipoid Pneumonia Complicated by Mineral Oil Aspiration in a Patient with Chronic Constipation: a Case Report and Review
    Open Access Case Report DOI: 10.7759/cureus.9294 Exogenous Lipoid Pneumonia Complicated by Mineral Oil Aspiration in a Patient With Chronic Constipation: A Case Report and Review Hafiz Muhammad Jeelani 1 , Muhammad Mubbashir Sheikh 2 , Belaal Sheikh 3, 4 , Hafiz Mahboob 5 , Anchit Bharat 6 1. Internal Medicine, Rosalind Franklin University of Medicine and Science, McHenry, USA 2. Oncology, Northwestern University Feinberg School of Medicine, Chicago, USA 3. Internal Medicine, Rosalind Franklin University of Medicine and Science, North Chicago, USA 4. Internal Medicine, Chicago Medical School, North Chicago, USA 5. Pulmonary and Critical Care Medicine, University of Nevada Las Vegas School of Medicine, Las Vegas, USA 6. Internal Medicine, Indiana University Health Ball Memorial Hospital, Muncie, USA Corresponding author: Hafiz Muhammad Jeelani, [email protected] Abstract Exogenous lipoid pneumonia is a rare and frequently misdiagnosed lung disease. It occurs as an inflammatory reaction secondary to either aspiration or inhalation of lipids. Our patient had a history significant for recurrent pneumonia and the use of mineral oil for chronic constipation. A chest computed tomography showed multifocal consolidative opacities with areas of low attenuation, highly suspicious of exogenous lipid pneumonia. The diagnosis was confirmed with combined bronchoalveolar lavage and transbronchial lung biopsy that showed lipid-laden macrophages consistent with exogenous lipoid pneumonia. After thorough medication review, apart from mineral oil, no other contributing factors were found. A diagnosis of exogenous lipoid pneumonia associated with the use of mineral oil made and successfully managed by stopping the offending agent and supportive antibiotics. Categories: Internal Medicine, Medical Education, Pulmonology Keywords: lipoid pneumonia, mineral oil, constipation, bal lavage, macrophages Introduction Lipoid pneumonia has been identified as a non-infectious cause of recurrent aspiration pneumonia in 1- 2.5% cases.
    [Show full text]
  • PNEUMONIAS Pneumonia Is Defined As Acute Inflammation of the Lung
    PNEUMONIAS Pneumonia is defined as acute inflammation of the lung parenchyma distal to the terminal bronchioles which consist of the respiratory bronchiole, alveolar ducts, alveolar sacs and alveoli. The terms 'pneumonia' and 'pneumonitis' are often used synonymously for in- flammation of the lungs, while 'consolidation' (meaning solidification) is the term used for macroscopic and radiologic appearance of the lungs in pneumonia. PATHOGENESIS. The microorganisms gain entry into the lungs by one of the following four routes: 1. Inhalation of the microbes. 2. Aspiration of organisms. 3. Haematogenous spread from a distant focus. 4. Direct spread from an adjoining site of infection. Failure of defense me- chanisms and presence of certain predisposing factors result in pneumonias. These condi- tions are as under: 1. Altered consciousness. 2. Depressed cough and glottic reflexes. 3. Impaired mucociliary transport. 4. Impaired alveolar macrophage function. 5. Endo- bronchial obstruction. 6. Leucocyte dysfunctions. CLASSIFICATION. On the basis of the anatomic part of the lung parenchyma involved, pneumonias are traditionally classified into 3 main types: 1. Lobar pneumonia. 2. Bronchopneumonia (or Lobular pneumonia). 3. Interstitial pneumonia. A. BACTERIAL PNEUMONIA Bacterial infection of the lung parenchyma is the most common cause of pneumonia or consolidation of one or both the lungs. Two types of acute bacterial pneumonias are dis- tinguished—lobar pneumonia and broncho-lobular pneumonia, each with distinct etiologic agent and morphologic changes. 1. Lobar Pneumonia Lobar pneumonia is an acute bacterial infection of a part of a lobe, the entire lobe, or even two lobes of one or both the lungs. ETIOLOGY. Following types are described: 1.
    [Show full text]
  • High-Resolution Computed Tomography to Differentiate Chronic Diffuse
    Original article: Clinical research SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES 2016; 33; 355-371 © Mattioli 1885 High-resolution computed tomography to differentiate chronic diffuse infiltrative lung diseases with chronic multifocal consolidation patterns using logical analysis of data Constance de Margerie-Mellon1*, Geneviève Dion2*, Julien Darlay3, Imene Ridene4, Marianne Kambouchner5, Nadia Brauner3, Michel Brauner6, Dominique Valeyre7, Pierre-Yves Brillet6 1Department of Radiology, Hôpital Saint-Louis, Université Paris 7 Denis Diderot, Sorbonne Paris-Cité, Paris, France; 2 Department of Pneumology, Centre de Recherche de l’Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, Québec, Canada; 3 Labo- ratoire G-SCOP, Université Joseph Fourier, Grenoble, France; 4 Department of Radiology, Hôpital Abderrahmane Mami, Ariana, Tunisie; 5Department of Pathology, EA2363 Laboratory, Hôpital Avicenne, Université Paris 13, Sorbonne Paris Cité, Bobigny, France; 6 Department of Radiology, EA2363 Laboratory, Hôpital Avicenne, Université Paris 13, Sorbonne Paris Cité, Bobigny, France; 7Department of Pneumology, EA2363 Laboratory, Hôpital Avicenne, Université Paris 13, Sorbonne Paris Cité, Bobigny, France Abstract. Background: Chronic lung consolidation has a limited number of differential diagnoses requiring dis- tinct managements. The aim of the study was to investigate how logical analysis of data (LAD) can support their diagnosis at HRCT (high-resolution computed tomography). Methods: One hundred twenty-four patients were retrospectively included and classified into 8 diagnosis categories: sarcoidosis (n=35), connective tissue disease (n=21), adenocarcinoma (n=17), lymphoma (n=13), cryptogenic organizing pneumonia (n=11), drug-induced lung disease (n=9), chronic eosinophilic pneumonia (n =7) and miscellaneous (n=11). First, we investigated the patterns and models (association of patterns characterizing a disease) built-up by the LAD from combina- tions of HRCT attributes (n=51).
    [Show full text]
  • An Exotic Cause of Exogenous Lipoid Pneumonia
    Hindawi Publishing Corporation Case Reports in Pulmonology Volume 2016, Article ID 1035601, 5 pages http://dx.doi.org/10.1155/2016/1035601 Case Report Teppanyaki/Hibachi Pneumonitis: An Exotic Cause of Exogenous Lipoid Pneumonia Franck Rahaghi, Ali Varasteh, Roya Memarpour, and Basheer Tashtoush Department of Pulmonary and Critical Care Medicine, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd., Weston, FL 33331, USA Correspondence should be addressed to Franck Rahaghi; [email protected] Received 30 July 2016; Accepted 25 October 2016 Academic Editor: Fabio Midulla Copyright © 2016 Franck Rahaghi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Exogenous lipoid pneumonia (ELP) is a rare type of inflammatory lung disease caused by aspiration and/or inhalation of fatty substances and characterized by a chronic foreign body-type reaction to intra-alveolar lipid deposits. The usual clinical presentation occurs with insidious onset of nonspecific respiratory symptoms and radiographic findings that can mimic other pulmonary diseases. Diagnosis of ELP is often missed or delayed as it requires a high index of suspicion and familiarity with the constellation of appropriate history and radiologic and pathologic features. We herein report a case of occupational exposure to tabletop “Teppanyaki” entertainment cooking as a cause of ELP, confirmed by surgical lung biopsies in a 63-year-old Asian woman who worked as a Hibachi-Teppanyaki chef for 25 years. 1. Introduction 2. Case Presentation Lipoid pneumonia was first described by Laughlen in 1925, A 63-year-old Japanese woman was referred to the pul- in one adult, one infant, and two children after repeated monary clinic for evaluation of her interstitial lung disease inhalation of nasopharyngeal oil droplets [1].
    [Show full text]
  • Exogenous Lipoid Pneumonia Successfully Treated with Bronchoscopic Segmental Lavage Therapy
    Exogenous Lipoid Pneumonia Successfully Treated With Bronchoscopic Segmental Lavage Therapy Shota Nakashima MD, Yuji Ishimatsu MD PhD, Shintaro Hara MD PhD, Masanori Kitaichi MD PhD, and Shigeru Kohno MD PhD A 65-y-old Japanese man was referred to the respiratory medicine department because of abnormal radiologic findings. High-resolution chest computed tomography scans revealed a geographic dis- tribution of ground-glass opacities and associated thickening of the interlobular septa (crazy-paving patterns) in both lower lobes. He had a habit of drinking 400–500 mL of milk and 400–800 mL of canned coffee with milk every day. A swallowing function test revealed liquid dysphagia. Bron- choalveolar lavage fluid cytology findings showed multiple lipid-laden macrophages. Taken to- gether, these findings revealed exogenous lipoid pneumonia. We performed bronchoscopic segmen- tal lavage therapy 3 times in the left lung. After the treatment, the radiologic findings improved in both lungs. The patient has not experienced a recurrence of lipoid pneumonia in2ytodate. In conclusion, a case of exogenous lipoid pneumonia was successfully treated with bronchoscopic segmental lavage therapy. Key words: lipoid pneumonia; exogenous lipoid pneumonia; treatment; milk; bronchoscopic segmental lavage; multiple segmental bronchoalveolar lavages. [Respir Care 2015;60(1):e1–e5. © 2015 Daedalus Enterprises] Introduction Case Report Exogenous lipoid pneumonia is an uncommon form of A 65-y-old Japanese man was referred to the respiratory pneumonia that is related to the inhalation or aspiration of medicine department at our hospital because of abnormal fatty substances.1 Although there are reports of lipoid pneu- radiologic findings. He had undergone a left hepatic lo- monia being successfully treated with corticosteroids,2-4 bectomy 13 y prior because of hepatocellular carcinoma.
    [Show full text]
  • Exogenous Lipoid Pneumonia. Clinical and Radiological Manifestations
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Respiratory Medicine (2011) 105, 659e666 available at www.sciencedirect.com journal homepage: www.elsevier.com/locate/rmed REVIEW Exogenous lipoid pneumonia. Clinical and radiological manifestations Edson Marchiori a,b,*, Gla´ucia Zanetti b,c, Claudia Mauro Mano a,d, Bruno Hochhegger b,e a Fluminense Federal University, Rio de Janeiro, Brazil b Federal University of Rio de Janeiro, Rio de Janeiro, Brazil Received 19 August 2010; accepted 1 December 2010 Available online 23 December 2010 KEYWORDS Summary Exogenous lipoid Lipoid pneumonia results from the pulmonary accumulation of endogenous or exogenous lipids. pneumonia; Host tissue reactions to the inhaled substances differ according to their chemical characteris- Computed tomography; tics. Symptoms can vary significantly among individuals, ranging from asymptomatic to severe, Aspiration pneumonia; life-threatening disease. Acute, sometimes fatal, cases can occur, but the disease is usually Bronchoalveolar lavage; indolent. Possible complications include superinfection by nontuberculous mycobacteria, Lung diseases pulmonary fibrosis, respiratory insufficiency, cor pulmonale, and hypercalcemia. The radiolog- ical findings are nonspecific, and the disease presents with variable patterns and distribution. For this reason, lipoid pneumonia may mimic many other diseases. The diagnosis of exogenous lipoid pneumonia is based on a history of exposure to oil, characteristic radiological findings, and the presence of lipid-laden macrophages on sputum or BAL analysis. High-resolution computed tomography (HRCT) is the best imaging modality for the diagnosis of lipoid pneu- monia. The most characteristic CT finding in LP is the presence of negative attenuation values within areas of consolidation.
    [Show full text]
  • Pathogenesis of Experimental Pulmonary Alveolar Proteinosis
    Thorax: first published as 10.1136/thx.25.2.230 on 1 March 1970. Downloaded from Thorax (1970), 25, 230. Pathogenesis of experimental pulmonary alveolar proteinosis B. CORRIN and E. KING Department of Morbid Anatomy, St. Thomas's Hospital Medical School, London, S.E.I, and the Occupational Hygiene Service, Manchester University Rats exposed to various airborne dusts developed a condition identical to pulmonary alveolar proteinosis as seen in man. The experimental condition developed through a stage of endogenous lipid pneumonia, characterized by numerous large foamy macrophages widely distributed through- out the lung. These cells broke down to release a finely granular material which finally condensed to reproduce the appearances of alveolar proteinosis. Electron microscopy indicated that the alveolar material was produced by type II pneumocytes and may therefore represent puImonary surfactant. A study of the dust-handling mechanism showed that in affected animals macrophage mobility was seriously impaired. Recent experiments comparing the effect of similar groups exposed under identical conditions to various dusts on the rat lung have been compli- various quartz modifications including the same purecopyright. cated by a process which as it advances repro- quartz did not contract alveolar proteinosis. Two duces the histological appearances of pulmonary groups of 24 rats each served as controls and alveolar proteinosis (Rosen, Castleman, and remained free of disease. The animals were killed Liebow, 1958). This complication was first en- with coal gas at monthly intervals up to 27 months. Details of the dusts, dust exposure apparatus, dust http://thorax.bmj.com/ countered in rats exposed to an aluminium dust concentrations, and chemical methods are given else- cloud (Corrin, 1962).
    [Show full text]
  • Occupational Asthma Due to Oil Mists
    Thorax: first published as 10.1136/thx.43.3.200 on 1 March 1988. Downloaded from Thorax 1988;43:200-205 Occupational asthma due to oil mists A S ROBERTSON, D C WEIR, P SHERWOOD BURGE From the Occupational Lung Disease Unit, East Birmingham Hospital, Birmingham ABSTRACT Twenty five patients who were exposed to oil mists at their place of work were investigated for possible work related asthma. Serial peak expiratory flow recordings showed 13 to have definite work related asthma, seven equivocal work related asthma, and three asthma unrelated to work; two had normal recordings. Subjects with work related asthma often produced different patterns ofpeak flow response during the working week; patterns also varied between patients. Six of these patients had bronchial tests with oil from their place of work. Three had asthma induced by exposure to unused (clean) soluble oil and one reacted to used but not to clean oil. The challenge tests in the remaining two gave inconclusive results. It is concluded that occupational asthma due to oil mists is common, the peak flow response is heterogeneous, and the provoking agent within the oil may vary from worker to worker. Many workers, particularly in machine shops, are possible cause of lung cancer,'2"3 but this is un- occupationally exposed to oil mists. These may occur likely.' '5'4 Despite the fact that respiratory symptoms in high concentrations and often more than one oil is are more common in workers exposed to oil mists'6 '7copyright. in use.' Industrial oils are in common use as coolants, and are related to the ambient concentration of oil cutting fluids, and lubricants.
    [Show full text]